Inflammatory Bowel Disease Flashcards
(41 cards)
chrons disease symptoms
abdominal pain
diarrhoea
fever
weight loss
IBD aetiology
possible environmental trigger
genetically susceptible people
Environmental triggers to IBD
role of bacteria
diet
vaccination history
social factors
ethnicity
ulcerative colitis presents with
bloody diarrhoea
abdominal pain
weight loss
what is ulcerative colitis?
continuous inflammation with variable distribution and severity
clinical features of ulcerative colitis
more than 6 stools a day
fever
tachycardia
CRP raised
Anaemia
leucocytosis
thrombocytosis
chron’s disease is a patchy disease that presents with
skip lesions
chron’s disease clinical features
diarrhoea
abdominal pain
weight loss
malaise, lethargy, anorexia, N+V, low-grade fever
malabsorption (anaemia, vitamin deficiency)
CRP
C-reactive protein
test for inflammation
IBD tests that show inflammatory indices
High WCC
High ESR + CRP
High platelet count
Low Hb
Low albumin
ESR
erythrocyte sedimentation rate
test for inflammation - its a marker
Histology of ulcerative colitis
goblet cells are depleted
histology of chron’s disease
granulomas
Chron’s disease includes conditions such as
fistulae
peri- anal symptoms
IBD: Extra-intestinal manifestations
Eyes
uvetitis
conjunctivits
IBD: Extra-intestinal manifestations
joints
sacroilititis
arthritis
IBD: Extra-intestinal manifestations
liver and biliary tree
fatty change
gallstones
pericholangitis
cholestasis
a decrease in bile flow due to impaired secretion by hepatocytes or to obstruction of bile flow through intra-or extrahepatic bile ducts
Sclerosing cholangitis is an Associated liver disease of IBD. what is it?
disease of the bile ducts
multiple strictures
slowly and progressively can lead to cirrhosis
medical management of IBD
out patient
5ASA
steriods
immunosuppression
medical management of IBD
hospital
steriods
anticoagulation
rest
(occasionally surgery)
Aminosalicylates (5ASA)
group of anti-inflammatory drugs used to treat chrons and ulcerative colitis
5ASA in UC results in
reduced numer and severity of relapses
higher mucosal levels = greater benefit
5ASA treatment in UC leads to a reduced risk of
CRC
colorectal carcinoma